Lv4
788 积分 2023-08-17 加入
Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency The FAIR-HF2 DZHK05 Randomized Clinical Trial
8小时前
待确认
Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR‐HF2 DZHK05 trial): Sex‐specific outcomes
8小时前
待确认
The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease
20小时前
待确认
Iron deficiency and supplementation in heart failure
20小时前
待确认
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial
6天前
已完结
IRONMAN adds support for iron repletion in HF
6天前
已完结
Rationale and Design of the Dapagliflozin Effect on Cardiovascular Events in Acute Heart Failure (DAPA ACT HF)-TIMI 68 Trial
6天前
已完结
Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency: The FAIR-HF2 DZHK05 Randomized Clinical Trial
6天前
已完结
Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR‐HF2 DZHK05 trial): Sex‐specific outcomes
6天前
已完结
Ferric carboxymaltose and exercise capacity in heart failure with preserved ejection fraction and iron deficiency: the FAIR-HFpEF trial
6天前
已完结
皖公网安备34019202002308
